LEADER-4: blood pressure control in patients with type 2 diabetes and high cardiovascular risk: baseline data from the LEADER randomized trial

OBJECTIVE: As glucagon-like peptide-1 receptor agonists lower blood pressure (BP) in type 2 diabetes mellitus (T2DM), we examined BP control in relation to targets set by international bodies prior to randomization in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcom...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Hypertens
Main Authors: Petrie, John R., Marso, Steven P., Bain, Stephen C., Franek, Edward, Jacob, Stephan, Masmiquel, Luis, Leiter, Lawrence A., Haluzik, Martin, Satman, Ilhan, Omar, Mohamed, Shestakova, Marina, Van Gaal, Luc, Mann, Johannes F., Baeres, Florian M.M., Zinman, Bernard, Poulter, Neil R.
Format: Artigo
Sprog:Inglês
Udgivet: Lippincott Williams & Wilkins 2016
Fag:
ORIGINAL PAPERS: Diabetes mellitus
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4856174/
https://ncbi.nlm.nih.gov/pubmed/26855018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/HJH.0000000000000890
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker